The present disclosure provides a method for the surface modification of microstructured components having a polar surface, in particular for high-pressure applications. According to the method, a microstructured component is contacted, in particular treated, with a modification reagent, wherein the surface properties of the component are modified by chemical and/or physical interaction of the component surface and of the modification reagent.

A pump and valve arrangement (201), a dialysis system (10) comprising the pump and valve arrangement 201 and a method of operating a pump and valve arrangement (201). The pump and valve arrangement (201) has a dialyser having a semi-permeable membrane. The pump and valve arrangement (201) delivers dialysis fluid to and from the dialyser (12). The pump and valve arrangement (201) has a control system (450) configured to shuttle dialysis fluid between an inlet pump assembly and the dialyser (12) one or more times so as to agitate the surface of the semi-permeable membrane of the dialyser (12).

According to an aspect there is provided a method for automatic maintenance of a dialysis system. The dialysis system includes a plurality of filter sections where each filter section includes a blood flow channel, a dialysate flow channel, and a membrane separating the blood flow channel from the dialysate flow channel and having a plurality of pores through which substances are exchanged between a blood flow in the blood flow channel and a dialysate flow in the dialysate flow channel. The method includes determining, for each filter section of the plurality of filter sections, whether a maintenance criterion is fulfilled. The method also includes triggering a maintenance event for a filter section of the plurality of filter sections for which the maintenance criterion is fulfilled. The method also includes executing the maintenance event and optionally administering a thrombolytic agent to the blood flow channel of the filter section.

The present invention relates to a device for a respiration arrangement. The device comprises a conduit having a first opening connectable to an air/gas source such as a resuscitation bag, and a second opening connectable to a face mask, such that a fluid pathway along a longitudinal direction of the conduit is established from the first opening to the second opening. The device further comprises a flow constriction, arranged in the conduit which upon fluid flow through the conduit results in a pressure difference over the flow constriction, the flow constriction at least partly comprising a laminar flow section, wherein the device further comprises at least one pressure connecting port arranged in pressurized communication with fluid between the flow constriction and the first opening, and wherein the pressure connecting port is arranged in the longitudinal direction of the conduit.

A method for determining that a patient interface component comprising a vent has been replaced between therapy sessions of treatment of sleep disordered breathing, the method comprising: acquiring or receiving first vent flow rate data representing one or more estimated first vent flow rates of gas through a first vent of a patient interface in use during a first therapy session; acquiring or receiving second vent flow rate data representing one or more estimated second vent flow rates of gas through a second vent of a patient interface in use during a second therapy session after the first therapy session; and identifying, by comparison of the second vent flow rate data to the first vent flow rate data, a difference in resistance to flow through the first vent than through the second vent indicating that the second vent is not the same vent as the first vent.

Methods of assembling a manifold for a medical waste collection system. A flapper valve unit is secured to a head of a cap. A filter element is positioned within a shell. Basket hands of the filter element are fitted between first pairs of ribs of the cap skirt. Fingers of the shell are fitted between second pairs of ribs of the cap skirt. The cap is secured to the shell to cover an open distal end of the shell. A drip stop is secured to the proximal end base of the shell to seat within the outlet opening. Ears may be fitted through holes defined by the flapper valve unit and cap holes defined by the cap so as to snap lock to the head of the cap. The hub of the flapper valve unit may be compressed with the ears snap locked to the head of the cap.

An arrangement and a process filter out at least one gas from a gas mixture. A filter unit (4) of the filter arrangement comprises an inlet and an outlet and is adapted to filter the gas out of the gas mixture while the gas mixture flows through the filter unit (4). The filter unit (4) takes up the gas and heats up in the process. A filter temperature sensor (46, 46.2) of the filter arrangement is adapted to measure at least once an indicator of the temperature in a first measuring area (MP, MP.2) inside the filter unit (4). Depending on the measured temperature, a message is generated and output in a form perceptible by a human being. This message includes information about the current state of the filter unit (4).

An indirect drain flush system incorporating hot water to facilitate the transport of kidney dialysis effluent to wastewater treatment facilities is provided. Heated water is discharged into a waste line through an air gap, and the heated water increases the molecular interchange of fatty substances in the dialysis effluent, decreasing the viscosity of those fatty substances and preventing them from coagulating or crystalizing on pipes and drains. An air admittance valve may prevent negative pressure from building up within the system.

A breathing treatment apparatus delivers breathing gas to a user. The apparatus may be configured to comprise one or more sensors for sensing microbial growth within the apparatus.

In an acute care setting, rapid onset of the therapeutic effects of medication is highly desirable. The invention provides in-line filters suitable for rapid delivery of a positively charged protein therapeutic via intravenous administration.